Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
Displaying 3801 - 3820 of 5974
Herbs Nutrition Corporation and Syed M. Jafry, In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
072-3147
Docket Number
9325
Milliman, Inc., In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
062-3189
Ingenix, Inc., In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
062 3190
Equitable Resources, Inc., Dominion Resources, Inc., Consolidated Natural Gas Company, and The Peoples Natural Gas Company, In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
061-0140
Docket Number
9322
Sili Neutraceuticals, LLC, and Brian McDaid, d/b/a Kaycon Ltd
Type of Action
Federal
Last Updated
FTC Matter/File Number
072-3124
Industrious Kid, Inc. and Jeanette Symons., U.S. (for the FTC)
Type of Action
Federal
Last Updated
FTC Matter/File Number
072-3082
Centro Natural Services, Inc., Xavier Rodriguez, and Rocio Diaz
Type of Action
Federal
Last Updated
FTC Matter/File Number
062-3064
Member Source Media LLC, d/b/a ConsumerGain.com, PremiumPerks.com, et al.; and Chris Sommer, individually and as Manager of Member Source Media LLC
Type of Action
Federal
Last Updated
FTC Matter/File Number
072-3042
Great American Products, Inc., et al.
Type of Action
Federal
Last Updated
FTC Matter/File Number
032 3247
Voice-Mail Broadcasting Corporation and Jesse Crowe., U.S. (for the FTC)
Type of Action
Federal
Last Updated
FTC Matter/File Number
052-3182
Diet Coffee, Inc., David Stocknoff, and David Attarian
Type of Action
Federal
Last Updated
FTC Matter/File Number
072-3052
Schering-Plough Corporation, In the Matter of
The Commission charged that Schering-Plough’s proposed $14.4 billion acquisition of Organon Biosciences N.V. threatened to substantially reduce competition in the U.S. market for three popular vaccines used to treat poultry, a staple in American food markets. The November 2007 order settling the charges required the sale of assets required to develop, manufacture, and market these vaccines to Wyeth. In addition, Schering-Plough was required to sign a supply and transition services agreement with Wyeth, under which Schering will provide the vaccines for a period of two years, allowing time for the necessary FDA approvals.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
071 0132
Displaying 3801 - 3820 of 5974